Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.55
-$2.47-10.73%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.22% | 9.89% | 10.02% | 11.89% | 12.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.22% | 9.89% | 10.02% | 11.89% | 12.72% |
| Cost of Revenue | 9.77% | 4.92% | 2.48% | 3.97% | 4.47% |
| Gross Profit | 13.67% | 12.96% | 14.91% | 17.10% | 18.24% |
| SG&A Expenses | 9.91% | 5.96% | 4.33% | 5.46% | 5.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.64% | 4.91% | 3.52% | 5.19% | 5.81% |
| Operating Income | 22.86% | 25.92% | 32.83% | 36.73% | 39.90% |
| Income Before Tax | 23.55% | 45.37% | 85.52% | 96.05% | 106.80% |
| Income Tax Expenses | 27.14% | 18.41% | 12.54% | 15.82% | 18.70% |
| Earnings from Continuing Operations | 22.35% | 57.51% | 135.81% | 154.51% | 175.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.35% | 57.51% | 135.81% | 154.51% | 175.11% |
| EBIT | 22.86% | 25.92% | 32.83% | 36.73% | 39.90% |
| EBITDA | 19.98% | 22.52% | 28.57% | 32.59% | 35.87% |
| EPS Basic | 22.07% | 57.18% | 135.11% | 153.31% | 173.03% |
| Normalized Basic EPS | 23.24% | 28.97% | 39.50% | 42.83% | 45.31% |
| EPS Diluted | 22.27% | 57.26% | 135.27% | 153.25% | 172.83% |
| Normalized Diluted EPS | 23.44% | 29.03% | 39.42% | 42.73% | 45.18% |
| Average Basic Shares Outstanding | 0.24% | 0.31% | 0.38% | 0.50% | 0.61% |
| Average Diluted Shares Outstanding | 0.14% | 0.28% | 0.43% | 0.56% | 0.69% |
| Dividend Per Share | 19.95% | 7.79% | -1.53% | -0.55% | -0.59% |
| Payout Ratio | 0.07% | -0.09% | -0.30% | -0.40% | -0.50% |